✦ LIBER ✦

Proteasome inhibitors: from in vitro uses to clinical trials

✍ Scribed by A. Jennifer Rivett; Robert C. Gardner

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 120 KB
Volume: 6
Category: Article
ISSN: 1075-2617
DOI: 10.1002/1099-1387(200009)6:9<478::aid-psc285>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tyrosine kinase inhibitors: From rationa

Tyrosine kinase inhibitors: From rational design to clinical trials

✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms. The inhibition of growth related kinases, especially tyrosine kinases, might provide new therapies for diseases such as cancer. The progre

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors: From Rational Design to Clinical Trials.

✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Roscovitine and Other Purines as Kinase

Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials

✍ Laurent Meijer; Eric Raymond 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 50 KB 👁 1 views

Predictors of response to dipeptidyl pep

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials

✍ Matteo Monami; Francesco Cremasco; Caterina Lamanna; Niccolò Marchionni; Edoardo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

## Aim: Dipeptidyl peptidase-4 (dpp-4) inhibitors are used in the treatment of type 2 diabetes. available sub-group analysis of clinical trials does not allow a clear identification of predictors of therapeutic response to these drugs. the aim of this study is the assessment of predictors of respon

Clinical predictors of response to acety

Clinical predictors of response to acetyl cholinesterase inhibitors: experience from routine clinical use in Newcastle

✍ S. Pakrasi; E. B. Mukaetova-Ladinska; I. G. McKeith; J. T. O'Brien 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## Background Acetyl Cholinesterase Inhibitors (AChEIs) have been in clinical use for the past five years in the UK for the symptomatic treatment of Alzheimer's disease (AD). There are few data on the patterns and predictors of response to AChEI therapy in routine clinical practice. We

AN ALTERNATIVE TO THE USE OF TWO-SIDED T

AN ALTERNATIVE TO THE USE OF TWO-SIDED TESTS IN CLINICAL TRIALS

✍ CHARLES W. DUNNETT; MICHAEL GENT 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB

There is a controversy in the literature concerning the use of one-and two-sided tests in clinical trials. Some contend that, when the research question relates to improved efficacy or safety, that is, the expected change is in one direction only, the hypothesis test should reflect this by being one